Transcarent To Acquire Accolade
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/26/2026
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Stock action shows confidence in central banks: BofA’s Hartnett
- Oil prices slide about 2% as US, Iran explore path out of war
- Why stocks held up despite rising yields and $100 oil? These 2 words explain it
- Barclays asks if equity markets are nearing the boiling point
- White House blocks CNN from Air Force One trip, Washington Post reports
- Merck and Daiichi Sankyo withdraw lung cancer drug application
- Exclusive-SK Hynix's Solidigm weighs IPO that could value the unit at up to $150 billion, sources say
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Fox Factory sells Marucci Sports for $225M, cuts debt
Truist Securities Reiterates Buy Rating on Accolade Inc. (ACCD)
January 8, 2025 12:07 PM ESTTruist Securities analyst Jailendra Singh reiterated a Buy rating and $7.50 price target on Accolade Inc. (NASDAQ: ACCD)
The analyst comments "Why We Like the Deal. We have long viewed mergers between digital health companies as being accretive in value proposition for end-markets as opposed to entities such as... More
